Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-08-2021 | Bullous Pemphigoid | Case report

Fulvestrant/letrozole/palbociclib

Cutaneous reactions: 11 case reports

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Chawla S, et al. Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience. Breast Cancer Research and Treatment 188: 535-545, No. 2, Jul 2021. Available from: URL: http://doi.org/10.1007/s10549-021-06169-9 Chawla S, et al. Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience. Breast Cancer Research and Treatment 188: 535-545, No. 2, Jul 2021. Available from: URL: http://​doi.​org/​10.​1007/​s10549-021-06169-9
Metadata
Title
Fulvestrant/letrozole/palbociclib
Cutaneous reactions: 11 case reports
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-01355-8

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Diflucortolone

Case report

Multiple drugs

Case report

Clozapine

Case report

Multiple drugs